Intraperitoneal disease dissemination patterns are associated with residual disease, extent of surgery, and molecular subtypes in advanced ovarian cancer
Authors:
- 1 December 2017
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 147 (3) , 503-508
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Does Aggressive Surgery Improve Outcomes? Interaction Between Preoperative Disease Burden and Complex Surgery in Patients With Advanced-Stage Ovarian Cancer: An Analysis of GOG 182Journal of Clinical Oncology, 2015
- Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian CancerJNCI: Journal of the National Cancer Institute, 2014
- The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: A gynecologic oncology group studyGynecologic Oncology, 2011
- Identification of patient groups at highest risk from traditional approach to ovarian cancer treatmentGynecologic Oncology, 2011
- Intra‐abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancerJournal of Surgical Oncology, 2009
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical OutcomeClinical Cancer Research, 2008
- Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancerAmerican Journal of Obstetrics and Gynecology, 2007
- What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?Gynecologic Oncology, 2006
- Aggressive Surgical Effort and Improved Survival in Advanced-Stage Ovarian CancerObstetrics & Gynecology, 2006
- Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group StudyJournal of Clinical Oncology, 2003